#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Short stature homeobox gene mutation Epstein-Barr virus associated lymphoproliferative disorder Glomerulonephritis membranoproliferative Postprandial hypoglycaemia Follicular lymphoma stage III Duchenne muscular dystrophy Duchenne muscular dystrophy gene carrier Meningitis meningococcal PIK3CA-activated mutation Soft tissue sarcoma Hypochromic anaemia Human papilloma virus immunisation Adenocarcinoma pancreas Raynaud's phenomenon More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Trials in Disease Atypical haemolytic uraemic syndrome – Treatment Hyperoxaluria – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Synovial sarcoma metastatic – Diagnostics Alveolar rhabdomyosarcoma Synovial sarcoma – Life with Disease Haemophilia A without inhibitors – Trials in Disease Breast angiosarcoma – Life with Disease Leiomyosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pbf-999 4-Hydroxy-N-Desmethyltamoxifen Tinzaparin Sodium YL201 Acalabrutinib Apraglutide Mitazalimab Prx005 Nystatin Semaglutide Messenger Rna Encoding Cas9 Testosterone Vidofludimus Calcium Englumafusp Alfa DUVELISIB VIPOGLANSTAT Teverelix Tetracycline Hydrochloride Cetuximab Solrikitug More therapies…

    Learn about Your Condition

    Aortic aneurysm Myxofibrosarcoma IgA nephropathy Breast cancer Oropharyngeal cancer recurrent Cystic fibrosis lung Cardiac ventricular thrombosis Large cell lung cancer Stevens-Johnson syndrome Hip fracture Osteopenia Post procedural oedema Arrhythmia supraventricular Epiphysiolysis Corneal graft failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on Adjusting Omalizumab Dosage for Patients with Severe Allergic Asthma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Omalizumab
    Spain

  • Study on the Safety and Effectiveness of Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells for Treating Fecal Incontinence in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Anal incontinence
    Investigated Drugs:
    • Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
    Spain

  • Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Pegaspargase
    • Rituximab
    Croatia Greece Hungary Slovenia

  • Study of Brentuximab Vedotin with Drug Combination for Untreated CD30-expressing Peripheral T-cell Lymphoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Brentuximab Vedotin
    • Cyclophosphamide
    • Doxorubicin
    Czechia

  • A Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoxia
    • Pulmonary hypertension
    • Cardiac failure
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on High vs. Low Dose Bupivacaine Hydrochloride and Epinephrine for Pain Relief After Aortic Valve Replacement Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Epinephrine
    Belgium
Previous Page
1 … 16 17 18 19 20 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!